ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
Eqz
|
279 |
94K |
42 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
279
|
94K
|
42
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
Eqz
|
279 |
94K |
10 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
279
|
94K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
Eqz
|
279 |
94K |
19 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
279
|
94K
|
19
|
|
ASX - By Stock
|
TSK |
Re:
Ann: TASK agrees to scheme agreement with PAR Technology
|
|
Eqz
|
63 |
30K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
63
|
30K
|
3
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
Eqz
|
111 |
50K |
1 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
111
|
50K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
Eqz
|
163 |
56K |
15 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
163
|
56K
|
15
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
Eqz
|
111 |
50K |
4 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
111
|
50K
|
4
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
Eqz
|
111 |
50K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
111
|
50K
|
4
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
Eqz
|
111 |
50K |
5 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
111
|
50K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Eqz
|
1.4K |
562K |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
1.4K
|
562K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Eqz
|
1.4K |
562K |
9 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
1.4K
|
562K
|
9
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Eqz
|
175 |
42K |
6 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
175
|
42K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Interim Analyses of Clinical Trials
|
|
Eqz
|
185 |
53K |
14 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
185
|
53K
|
14
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Eqz
|
175 |
42K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
175
|
42K
|
3
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Eqz
|
175 |
42K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
175
|
42K
|
6
|
|
ASX - By Stock
|
TRP |
Tissue Repair: Hidden Gem in Biotech!
|
|
Eqz
|
175 |
42K |
9 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
175
|
42K
|
9
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
36 |
8.4K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
36
|
8.4K
|
0
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
Eqz
|
111 |
50K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
111
|
50K
|
2
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
36 |
8.4K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
36
|
8.4K
|
2
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
Eqz
|
111 |
50K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
111
|
50K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Eqz
|
41 |
14K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
41
|
14K
|
1
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
16 |
3.4K |
2 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
16
|
3.4K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Eqz
|
41 |
14K |
3 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
41
|
14K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
TA
|
|
Eqz
|
20 |
5.5K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
20
|
5.5K
|
1
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
16 |
3.4K |
1 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
16
|
3.4K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Eqz
|
41 |
14K |
4 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
41
|
14K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
TA
|
|
Eqz
|
20 |
5.5K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
20
|
5.5K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
Eqz
|
34 |
10K |
12 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
34
|
10K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Eqz
|
21 |
6.0K |
3 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
21
|
6.0K
|
3
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
36 |
8.4K |
3 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
36
|
8.4K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
Eqz
|
517 |
127K |
5 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
517
|
127K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
Eqz
|
517 |
127K |
12 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
517
|
127K
|
12
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
16 |
3.4K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
16
|
3.4K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Investor presentation - Euroz Hartleys Healthcare Forum
|
|
Eqz
|
9 |
4.4K |
3 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
9
|
4.4K
|
3
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
16 |
3.4K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
16
|
3.4K
|
2
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eqz
|
36 |
8.4K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
36
|
8.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Eqz
|
21 |
6.0K |
5 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
21
|
6.0K
|
5
|
|
ASX - By Stock
|
TSK |
Re:
Ann: Quarterly Activity Report - Q3 FY24
|
|
Eqz
|
4 |
2.5K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
4
|
2.5K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: OSX achieves 100k implants, to accelerate commercialisation
|
|
Eqz
|
4 |
1.6K |
3 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
4
|
1.6K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
|
|
Eqz
|
37 |
13K |
4 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
|
|
Eqz
|
37 |
13K |
5 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
37
|
13K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
Eqz
|
47 |
27K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
47
|
27K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
Eqz
|
47 |
27K |
2 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
47
|
27K
|
2
|
|
ASX - By Stock
|
ZLD |
Summary
|
|
Eqz
|
47 |
27K |
1 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
47
|
27K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
Eqz
|
640 |
226K |
10 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
640
|
226K
|
10
|
|
ASX - By Stock
|
TSK |
Re:
Merger capital raise
|
|
Eqz
|
5 |
2.0K |
1 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
5
|
2.0K
|
1
|
|
ASX - By Stock
|
TSK |
Re:
Merger capital raise
|
|
Eqz
|
5 |
2.0K |
2 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
5
|
2.0K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Eqz
|
1.4K |
562K |
28 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
1.4K
|
562K
|
28
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024
|
|
Eqz
|
37 |
13K |
15 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
37
|
13K
|
15
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Eqz
|
12 |
4.0K |
2 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
12
|
4.0K
|
2
|
|